KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Receivables (2016 - 2025)

Exact Sciences has reported Receivables over the past 12 years, most recently at $298.7 million for Q4 2025.

  • Quarterly Receivables rose 8.65% to $298.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $298.7 million through Dec 2025, up 8.65% year-over-year, with the annual reading at $298.7 million for FY2025, 8.65% up from the prior year.
  • Receivables was $298.7 million for Q4 2025 at Exact Sciences, down from $337.9 million in the prior quarter.
  • Over five years, Receivables peaked at $386.0 million in Q2 2025 and troughed at $158.0 million in Q4 2022.
  • The 5-year median for Receivables is $252.9 million (2021), against an average of $252.6 million.
  • Year-over-year, Receivables skyrocketed 82.89% in 2021 and then decreased 27.05% in 2022.
  • A 5-year view of Receivables shows it stood at $216.6 million in 2021, then dropped by 27.05% to $158.0 million in 2022, then skyrocketed by 55.23% to $245.3 million in 2023, then grew by 12.04% to $274.9 million in 2024, then grew by 8.65% to $298.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Receivables are $298.7 million (Q4 2025), $337.9 million (Q3 2025), and $386.0 million (Q2 2025).